Itacitinib Synthesis with Modular Protected Intermediates

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

There is a growing demand for new and more efficient routes to synthesize itacitinib, a potent JAK1 inhibitor, and its related intermediates to treat inflammatory diseases and other conditions, as existing methods are inadequate.

Innovation Solution

The processes involve reacting specific compounds and their salts to form itacitinib through various synthetic steps, including the use of amino protecting groups, deprotection, and coupling agents, utilizing solvents and reagents like Grignard catalysts and Vilsmeier reagents to achieve the desired product.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If existing synthesis methods are used to prepare itacitinib, then the basic synthesis capability is maintained, but the synthesis efficiency and productivity are inadequate

Engineering Contradiction:

Improvesynthesis efficiencyVSAvoidsynthesis time

Core Design Contradiction:

ProductivityVSLoss of time

Solution Approach 1:

The synthesis route is divided into distinct modular steps including formation of compound 1a, conversion to compound 2a, coupling with compound 3 to form compound 4, and final deprotection to yield itacitinib. Each step is optimized independently with specific reagents and conditions, allowing parallel development and optimization of individual steps to improve overall productivity.

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

Compound 1a is prepared in advance through a optimized sequence involving reaction of compound 12a with t-butyldimethylsilyl chloride followed by Grignard reaction with MeMgBr. This preliminary preparation of key intermediate 1a enables more efficient subsequent coupling steps and reduces overall synthesis time for itacitinib production.

Inventive Principle:

Principle #10Preliminary action

2Manufacturing precision

If existing synthesis methods are used, then the basic product output is achieved, but the manufacturing precision and quality consistency are insufficient

Engineering Contradiction:

Improvesynthesis quality consistencyVSAvoidproduct quality reliability

Core Design Contradiction:

Manufacturing precisionVSReliability

Solution Approach 1:

The synthesis method specifies precise parameter ranges including temperature control (e.g., 0°C to room temperature for silylation, specific temperatures for Grignard reactions), stoichiometric ratios of reagents, and controlled reaction times. These parameter optimizations ensure consistent product quality and high purity itacitinib with reduced batch-to-batch variability.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

Protecting groups such as t-butyldimethylsilyl are introduced as intermediaries to protect sensitive functional groups during synthesis, ensuring selective reactions and maintaining product purity. The deprotection step at the end cleanly removes these intermediaries to yield high-quality itacitinib with consistent properties.

Inventive Principle:

Principle #24Intermediary (Mediator)

3Ease of manufacture

If complex synthesis routes are used, then the product can be synthesized, but the device complexity and process complexity increase

Engineering Contradiction:

Improvesynthesis process simplicityVSAvoidsynthesis process complexity

Core Design Contradiction:

Ease of manufactureVSDevice complexity

Solution Approach 1:

The method extracts and eliminates unnecessary intermediate steps and reagents from traditional synthesis routes. The optimized pathway directly converts readily available starting materials (compounds 12a and 3) through essential transformations to itacitinib, removing redundant operations and simplifying the overall manufacturing process while maintaining product quality.

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The synthesis method uses versatile reagents and reaction conditions that can be applied across multiple steps. For example, the Grignard reaction conditions and silylation methodology are standard organic transformations that can be performed with common laboratory equipment and reagents, reducing the need for specialized apparatus and simplifying manufacturing.

Inventive Principle:

Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These processes enable the efficient production of itacitinib and its salts, providing a more effective route for synthesizing this JAK1 inhibitor, which is crucial for treating inflammatory diseases and other conditions.

Implementation Method 1

reacting a compound of formula 2P: or a salt thereof, with MeMgBr in the presence of a Grignard catalyst to form a compound of formula 1aP

Methodology Applied

Scientific EffectGrignard reaction: Chemical Bonding

Implementation Method 2

reacting the compound of formula 1a, or the salt thereof, with a Vilsmeier reagent formed from dimethylformamide and a chlorinating agent to form the salt of formula 2d

Methodology Applied

Scientific EffectVilsmeier-Haack reaction: Chemical Bonding